JPRN-jRCTs032200108已完成1 期
Clinical research to confirm the safety of bone regenerationpromoting materials based on type 1 collagen - Synthetic bone graft substitute transplantation for the socket preservation
Tobita Morikuni0 个研究点目标入组 0 人开始时间: 2020年9月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable(—)
- 性别
- All
入选标准
- •Patients who perform tooth extraction on the premise of the dental implant treatment
排除标准
- •-Active generalized periodontal disease; evident periapical radiolucencies or abscesses
- •-autoimmune disorders; taking or having a history of bisphosphonate medications or Denosumab (history of MRONJ (medication-related osteonecrosis of the jaw)/BRONJ (bisphosphonate-related osteonecrosis of the jaw))
- •-Current taking methotrexate(MTX) or steroids.
- •-Congenital or metabolic bone disorders; or uncontrolled diabetes.
- •-Current or former smoker or user of chewing tobacco or nicotine-containing products
- •-Females who are pregnant, breastfeeding, or are planning to conceive during their enrollment in the clinical investigation.
- •-History of any severe allergic or anaphylactic reactions to collagen or gelatin, or current sensitivity to collagen or gelatin.
- •-Have a history of complicate malignant tumor.
研究者
相似试验
已完成
不适用
Safety investigations for the bone regenerative medicine using growth factors secreted from the patients' own stem cellsBone defects due to removal of teeth, PeriodontitisJPRN-UMIN000011286agoya University10
尚未招募
Unknown
Clinical study for efficacy and safety of bone marrow derived cell concentrate and allogenic dermal matrix complex therapy in diabetic foot ulcerEndocrine, nutritional and metabolic diseasesKCT0009122Soon Chun Hyang University Hospital Bucheon58
已完成
1 期
Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb IschemiaCritical Limb IschemiaNCT01472289TotipotentSC Scientific Product Pvt. Ltd.17
撤回
3 期
Bone Healing Accelerant Versus Standard of Care for Open Tibia FracturesTibial FracturesNCT03826784Carmell Therapeutics Corporation
撤回
2 期
Multiregion BHA in Open Tibia FracturesTibial FracturesNCT04056429Carmell Therapeutics Corporation
